Cargando…
S41. SHORT- AND LONG-TERM OUTCOMES OF VITAMIN D SUPPLEMENTATION IN CLOZAPINE TREATED CHRONIC SCHIZOPHRENIA PATIENTS
BACKGROUND: Vitamin D deficiency is highly prevalent in patients with psychosis. While accumulating data suggests that vitamin D deficiency may be involved in the clinical and metabolic outcomes of schizophrenia, there are no vitamin D supplementation studies in this context. Objective: To assess th...
Autores principales: | Krivoy, Amir, Onn, Roy, Vilner, Yael, Friedman, Zvika, Weizman, Abraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888585/ http://dx.doi.org/10.1093/schbul/sby018.828 |
Ejemplares similares
-
Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
por: Krivoy, Amir, et al.
Publicado: (2017) -
41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018) -
M152. IS MEDICAL SERVICES UTILISATION A MODERATING FACTOR OF EARLY EXCESS MORTALITY IN PATIENTS WITH SCHIZOPHRENIA
por: Krivoy, Amir, et al.
Publicado: (2020) -
Clozapine blood level assessment using a point-of-care device:
feasibility and reliability
por: Kamhi-Nesher, Shiri, et al.
Publicado: (2022) -
Outcomes in treatment-resistant schizophrenia: symptoms, function and
clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)